Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
1,863
Views
21
CrossRef citations to date
0
Altmetric
Back Matter

T cell receptor repertoire as a prognosis marker for heat shock protein peptide complex-96 vaccine trial against newly diagnosed glioblastoma

Yang Zhanga Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;b China National Clinical Research Center for Neurological Diseases, Beijing, ChinaView further author information
,
Poorva Mudgalc TCRCure Biopharma, Durham, NC, USAView further author information
,
Liuyang Wangd Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC, USAView further author information
,
Haiyang Wuc TCRCure Biopharma, Durham, NC, USAView further author information
,
Na Huanga Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;b China National Clinical Research Center for Neurological Diseases, Beijing, ChinaView further author information
,
Peter B. Alexanderc TCRCure Biopharma, Durham, NC, USAView further author information
,
Zhixian Gaoa Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;b China National Clinical Research Center for Neurological Diseases, Beijing, ChinaView further author information
,
Nan Jia Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;b China National Clinical Research Center for Neurological Diseases, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Qi-Jing Lie Department of Immunology, Duke University Medical Center, Durham, NC, USACorrespondence[email protected]
View further author information
 show all
Article: 1749476 | Received 01 Nov 2019, Accepted 11 Mar 2020, Published online: 12 Apr 2020

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alice Giotta Lucifero & Sabino Luzzi. (2022) Emerging immune-based technologies for high-grade gliomas. Expert Review of Anticancer Therapy 22:9, pages 957-980.
Read now

Articles from other publishers (20)

B. Bardwell, J. Bay & Z. Colburn. (2024) The clinical applications of immunosequencing. Current Research in Translational Medicine 72:3, pages 103439.
Crossref
Pramod K. Srivastava. (2024) Cancer neoepitopes viewed through negative selection and peripheral tolerance: a new path to cancer vaccines. Journal of Clinical Investigation 134:5.
Crossref
Prathap Somu, Sonali Mohanty, Nagaraj Basavegowda, Akhilesh Kumar Yadav, Subhankar Paul & Kwang-Hyun Baek. (2024) The Interplay between Heat Shock Proteins and Cancer Pathogenesis: A Novel Strategy for Cancer Therapeutics. Cancers 16:3, pages 638.
Crossref
Lu Wang, Zhiyuan Xu, Wei Zhang, Lin Li, Xiao Liu & Jing Zhang. (2024) Comprehensive characterization and database construction of immune repertoire in the largest Chinese glioma cohort. iScience 27:1, pages 108661.
Crossref
Wei Kang, Zhixiao Mo, Wenshan Li, Haifeng Ma & Qiang Zhang. (2023) Heterogeneity and individualized treatment of microenvironment in glioblastoma (Review). Oncology Reports 50:6.
Crossref
Alena Mazurakova, Zuzana Solarova, Lenka Koklesova, Martin Caprnda, Robert Prosecky, Artur Khakymov, Denis Baranenko, Peter Kubatka, Ladislav Mirossay, Peter Kruzliak & Peter Solar. (2023) Heat shock proteins in cancer – Known but always being rediscovered: Their perspectives in cancer immunotherapy. Advances in Medical Sciences 68:2, pages 464-473.
Crossref
Sukrit Mahajan, Mirko H. H. Schmidt & Ulrike Schumann. (2023) The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens. Cancers 15:7, pages 2024.
Crossref
Xing Huang, Gang Zhang, Tian-Yu Tang, Xiang Gao & Ting-Bo Liang. (2022) Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine. Military Medical Research 9:1.
Crossref
Wentao Hu, Hongyu Liu, Ze Li, Jialin Liu & Ling Chen. (2022) Impact of molecular and clinical variables on survival outcome with immunotherapy for glioblastoma patients: A systematic review and meta‐analysis. CNS Neuroscience & Therapeutics 28:10, pages 1476-1491.
Crossref
Yi Wang, Chunzhao Li, Xiaohan Chi, Xijian Huang, Hua Gao, Nan Ji & Yang Zhang. (2022) Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination. Frontiers in Oncology 12.
Crossref
Dimitrios Mathios, Siddhartha Srivastava, Timothy Kim, Chetan Bettegowda & Michael Lim. (2021) Emerging Technologies for Non-invasive Monitoring of Treatment Response to Immunotherapy for Brain Tumors. NeuroMolecular Medicine 24:2, pages 74-87.
Crossref
Maksim Sorokin, Elizaveta Rabushko, Julian Markovich Rozenberg, Tharaa Mohammad, Aleksander Seryakov, Marina Sekacheva & Anton Buzdin. (2022) Clinically relevant fusion oncogenes: detection and practical implications. Therapeutic Advances in Medical Oncology 14, pages 175883592211441.
Crossref
Santiago Cabezas-Camarero, Rebeca Pérez-Alfayate, Vanesa García-Barberán, María Carmen Polidura, María Natividad Gómez-Ruiz, Isabel Casado-Fariñas, Issa Ahmad Subhi-Issa, José Carlos Plaza Hernández, Pilar Garre, Isabel Díaz-Millán & Pedro Pérez-Segura. (2022) Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma. Therapeutic Advances in Medical Oncology 14, pages 175883592211008.
Crossref
Gábor Hutóczki, József Virga, Zsuzsanna Birkó & Almos Klekner. (2021) Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity. International Journal of Molecular Sciences 22:18, pages 10005.
Crossref
Dana Mitchell, Jack Shireman, Elizabeth A. Sierra Potchanant, Montserrat Lara-Velazquez & Mahua Dey. (2021) Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The Quest for Striking the Right Balance. Frontiers in Cellular Neuroscience 15.
Crossref
Stephen C. Frederico, John C. Hancock, Emily E. S. Brettschneider, Nivedita M. Ratnam, Mark R. Gilbert & Masaki Terabe. (2021) Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma. Frontiers in Oncology 11.
Crossref
De Wei, Shanghang Shen, Kun Lin, Feng Lu, Pengfeng Zheng, Shizhong Wu & Dezhi Kang. (2021) NPC2 as a Prognostic Biomarker for Glioblastoma Based on Integrated Bioinformatics Analysis and Cytological Experiments. Frontiers in Genetics 12.
Crossref
Nivedita M Ratnam, Stephen C Frederico, Javier A Gonzalez & Mark R Gilbert. (2021) Clinical correlates for immune checkpoint therapy: significance for CNS malignancies. Neuro-Oncology Advances 3:1.
Crossref
Ahmed Habib, Matthew Pease, Chowdari V. Kodavali, Nduka Amankulor & Pascal O. Zinn. (2021) A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care. Journal of Neuro-Oncology 151:2, pages 103-112.
Crossref
Chunzhao Li, Yifei Du, Yang Zhang & Nan Ji. (2020) Immunotherapy with heat shock protein 96 to treat gliomas. Chinese Neurosurgical Journal 6:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.